Hiroshi Yokouchi
Overview
Explore the profile of Hiroshi Yokouchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
747
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tateishi K, Mizugaki H, Ikezawa Y, Morita R, Yokoo K, Sumi T, et al.
Jpn J Clin Oncol
. 2024 Dec;
55(3):253-260.
PMID: 39656678
Background: In the first-line treatment of elderly patients with advanced-stage non-small cell lung cancer (NSCLC) with high programmed death-ligand 1 (PD-L1) expression (tumor proportion score ≥ 50%), this study aimed...
2.
Hashimoto K, Morinaga D, Asahina H, Ishidoya M, Kikuchi H, Yokouchi H, et al.
JTO Clin Res Rep
. 2024 Oct;
5(11):100715.
PMID: 39403627
Introduction: Oligometastasis and oligoprogression (OP) has not been adequately defined in extensive-stage SCLC (ES-SCLC) and may be a good indication for adding local treatment. Therefore, this multicenter study aimed to...
3.
Morgensztern D, Ready N, Johnson M, Dowlati A, Choudhury N, Carbone D, et al.
Clin Cancer Res
. 2024 Sep;
30(22):5042-5052.
PMID: 39287821
Purpose: Seizure-related homolog protein 6 (SEZ6) is a novel target expressed in small cell lung cancer (SCLC). ABBV-011, a SEZ6-targeted antibody conjugated to calicheamicin, was evaluated in a phase I...
4.
Furuta M, Horinouchi H, Yokota I, Yamaguchi T, Itoh S, Fukui T, et al.
Cancer Sci
. 2024 Sep;
115(11):3705-3717.
PMID: 39278260
Locoregional recurrence of non-small-cell lung cancer (NSCLC) after complete resection lacks standard treatment. Durvalumab after chemoradiotherapy (CRT) or CRT alone is often selected in daily clinical practice for patients with...
5.
Ikezawa Y, Morita R, Mizugaki H, Tateishi K, Yokoo K, Sumi T, et al.
Cancer Med
. 2024 Jul;
13(14):e70036.
PMID: 39030894
Background: Selecting pembrolizumab monotherapy (MONO) or pembrolizumab plus platinum-based chemotherapy (COMB) for patients with nonsmall cell lung cancer (NSCLC) and high programmed death-ligand 1 (PD-L1) expression is an important issue...
6.
Okahisa M, Udagawa H, Matsumoto S, Kato T, Yokouchi H, Furuya N, et al.
Lung Cancer
. 2024 Apr;
191:107798.
PMID: 38669727
Objectives: In this study, we explored the clinical outcomes of non-small cell lung cancer (NSCLC) patients with EGFR Exon20 in-frame insertions (Exon20ins), and the impact of the location of Exon20ins...
7.
Nishioka N, Imai H, Endo M, Notsu A, Doshita K, Igawa S, et al.
Target Oncol
. 2024 Apr;
19(3):423-433.
PMID: 38613731
Background: Although osimertinib is a promising therapeutic agent for advanced epidermal growth factor receptor (EGFR) mutation-positive lung cancer, the incidence of pneumonitis is particularly high among Japanese patients receiving the...
8.
Tsuji K, Mizugaki H, Yokoo K, Kobayashi M, Kawashima Y, Kimura N, et al.
Cancer Sci
. 2024 Jan;
115(4):1273-1282.
PMID: 38287788
Durvalumab has been administered to patients with unresectable stage III non-small cell lung cancer (NSCLC). However, it remains unclear whether durvalumab benefits these patients with epidermal growth factor receptor (EGFR)...
9.
Hagio K, Kikuchi J, Takada K, Tanabe H, Sugiyama M, Ohhara Y, et al.
Cancer Sci
. 2023 May;
114(8):3385-3395.
PMID: 37208840
Comprehensive genomic profiling (CGP) tests have been covered by public insurance in Japan for patients with advanced solid tumors who have completed or are completing standard treatments or do not...
10.
Morinaga D, Asahina H, Ito S, Honjo O, Tanaka H, Honda R, et al.
Cancer Med
. 2023 Mar;
12(10):11525-11541.
PMID: 36999734
Purpose: Immune-checkpoint inhibitors (ICIs) are effective against advanced non-small cell lung cancer (NSCLC). However, whether the efficacy and safety of ICI treatment in elderly patients are similar to those in...